๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm

โœ Scribed by J. H. Kehne; J. V. Cassella; M. Davis


Publisher
Springer
Year
1988
Tongue
English
Weight
627 KB
Volume
94
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Diazepam and flurazepam: Effects on cond
โœ Michael Davis ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› Springer ๐ŸŒ English โš– 667 KB

Diazepam (0.3, 0.6, 1.2, or 2.5mg/kg) produced a dose-dependent reduction of the potentiated startle effect where acoustic startle amplitude is normally increased in the presence of a light previously paired with a shock. Even the lowest dose tested (0.3 mg/kg) significantly attenuated potentiated s

A further investigation of the developme
โœ Pamela S. Hunt ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 2 views

This series of experiments was designed to reexamine the ontogenetic emergence of the fear-potentiated startle response in rats. Previous results (Hunt, Richardson, & Campbell, 1994) indicated that potentiated startle to a light conditioned stimulus (CS) paired with an acoustic unconditioned stimulu

Effects of the novel anxiolytics gepiron
โœ F. Gilbert; C. T. Dourish ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 429 KB

The effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by the 5-HT~A receptor agonist, 8-hydroxy-2-(di-npropylamino) tetralin (8-OH-DPAT), were examined. Gepirone dose-dependently increased feeding 2 and 4 h after injection, the magnitude of th

Effects of midazolam, DMCM and lindane o
โœ Theo H. Hijzen; Jef L. Slangen ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 460 KB

Forty-eight male Wistar rats were exposed to contingent light-shock combinations and 48 rats received light and shock stimuli in a random order. One day after fear conditioning the animals were tested for startle potentiation after injection of midazolam (0, 0.5, 1.0, 2.0 mg/kg, IP) or DMCM (methyl-